Publicacións en colaboración con investigadores/as de Karolinska Institute (6)

2022

  1. Challenges in cardiovascular pharmacogenomics implementation: a viewpoint from the European Society of Cardiology Working Group on Cardiovascular Pharmacotherapy

    European heart journal. Cardiovascular pharmacotherapy, Vol. 8, Núm. 1, pp. 100-103

2021

  1. Update on management of hypokalaemia and goals for the lower potassium level in patients with cardiovascular disease: A review in collaboration with the European Society of Cardiology Working Group on Cardiovascular Pharmacotherapy

    European Heart Journal - Cardiovascular Pharmacotherapy, Vol. 7, Núm. 6, pp. 557-567

2020

  1. Antithrombotic therapy and major adverse limb events in patients with chronic lower extremity arterial disease: Systematic review and meta-analysis from the European Society of Cardiology Working Group on Cardiovascular Pharmacotherapy in Collaboration with the European Society of Cardiology Working Group on Aorta and Peripheral Vascular Diseases

    European Heart Journal - Cardiovascular Pharmacotherapy, Vol. 6, Núm. 2, pp. 86-93

  2. Cardiovascular pharmacotherapy in older people: Challenges posed by cardiovascular drug prescription in the elderly

    European Heart Journal - Cardiovascular Pharmacotherapy

2018

  1. Non-insulin antidiabetic pharmacotherapy in patients with established cardiovascular disease: a position paper of the European Society of Cardiology Working Group on Cardiovascular Pharmacotherapy

    European Heart Journal, Vol. 39, Núm. 24, pp. 2274-2281

2013

  1. ESC guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD

    European Heart Journal, Vol. 34, Núm. 39, pp. 3035-3087